Immunogenicity 2672

summary
Sample ID
4069
Response
Negative
Tumor Type
Pancreatic cancer
Gene Symbol
FOLH1
Transcript ID
uc009ylz.3
HLA INFO
B*38:01
TCR INFO

No TCR info found!

T cell Tumor cell B*38:01
sequence
Full length protein sequence (704 aa)
MTAGS
1
SYPLF
6
LAAYA
11
CTGCL
16
AERLG
21
WFIKS
26
SNEAT
31
NITPK
36
HNMKA
41
FLDEL
46
KAENI
51
KKFLY
56
NFTQI
61
PHLAG
66
TEQNF
71
QLAKQ
76
IQSQW
81
KEFGL
86
DSVEL
91
AHYDV
96
LLSYP
101
NKTHP
106
NYISI
111
INEDG
116
NEIFN
121
TSLFE
126
PPPPG
131
YENVS
136
DIVPP
141
FSAFS
146
PQGMP
151
EGDLV
156
YVNYA
161
RTEDF
166
FKLER
171
DMKIN
176
CSGKI
181
VIARY
186
GKVFR
191
GNKVK
196
NAQLA
201
GAKGV
206
ILYSD
211
PADYF
216
APGVK
221
SYPDG
226
WNLPG
231
GGVQR
236
GNILN
241
LNGAG
246
DPLTP
251
GYPAN
256
EYAYR
261
RGIAE
266
AVGLP
271
SIPVH
276
PIGYY
281
DAQKL
286
LEKMG
291
GSAPP
296
DSSWR
301
GSLKV
306
PYNVG
311
PGFTG
316
NFSTQ
321
KVKMH
326
IHSTN
331
EVTRI
336
YNVIG
341
TLRGA
346
VEPDR
351
YVILG
356
GHRDS
361
WVFGG
366
IDPQS
371
GAAVV
376
HEIVR
381
SFGTL
386
KKEGW
391
RPRRT
396
ILFAS
401
WDAEE
406
FGLLG
411
STEWA
416
EENSR
421
LLQER
426
GVAYI
431
NADSS
436
IEGNY
441
TLRVD
446
CTPLM
451
YSLVH
456
NLTKE
461
LKSPD
466
EGFEG
471
KSLYE
476
SWTKK
481
SPSPE
486
FSGMP
491
RISKL
496
GSGND
501
FEVFF
506
QRLGI
511
ASGRA
516
RYTKN
521
WETNK
526
FSGYP
531
LYHSV
536
YETYE
541
LVEKF
546
YDPMF
551
KYHLT
556
VAQVR
561
GGMVF
566
ELANS
571
IVLPF
576
DCRDY
581
AVVLR
586
KYADK
591
IYSIS
596
MKHPQ
601
EMKTY
606
SVSFD
611
SLFSA
616
VKNFT
621
EIASK
626
FSERL
631
QDFDK
636
SKHVI
641
YAPSS
646
HNKYA
651
GESFP
656
GIYDA
661
LFDIE
666
SKVDP
671
SKAWG
676
EVKRQ
681
IYVAA
686
FTVQA
691
AAETL
696
SEVA
701
Mutation Information
DNA mutation:
None
Peptide Range:
163 ~ 187
Mut AA position:
175 (13 in Wild Type peptide)
Alignment
Wild Type:
"NYARTEDFFKLERDMKINCSGKIVI
||||||||||||.||||||||||||
Mutant:
NYARTEDFFKLEWDMKINCSGKIVI"
reference

Science, 2015

Immunogenicity of somatic mutations in human gastrointestinal cancers

Gene Name (from Reference) FOLH1

clinic trial
Checkpoint Blockade

None

ACT

None

Vaccination

None

Curative Effect

None

experiment
minimal_peptide

None

Antigen Type

TMG RNA

T-cell Source

TILs

APC Type

autologous DCs

Assay

IFNg ELISPOT assay